Cargando…
Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors
It is well documented that statins protect atherosclerotic patients from inflammatory changes and plaque instability in coronary arteries. However, the underlying mechanisms are not fully understood. Using a previously established mouse model for vulnerable atherosclerotic plaque, we investigated th...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016207/ https://www.ncbi.nlm.nih.gov/pubmed/24816562 http://dx.doi.org/10.1371/journal.pone.0097009 |
_version_ | 1782315467440914432 |
---|---|
author | Nie, Peng Li, Dandan Hu, Liuhua Jin, Shuxuan Yu, Ying Cai, Zhaohua Shao, Qin Shen, Jieyan Yi, Jing Xiao, Hua Shen, Linghong He, Ben |
author_facet | Nie, Peng Li, Dandan Hu, Liuhua Jin, Shuxuan Yu, Ying Cai, Zhaohua Shao, Qin Shen, Jieyan Yi, Jing Xiao, Hua Shen, Linghong He, Ben |
author_sort | Nie, Peng |
collection | PubMed |
description | It is well documented that statins protect atherosclerotic patients from inflammatory changes and plaque instability in coronary arteries. However, the underlying mechanisms are not fully understood. Using a previously established mouse model for vulnerable atherosclerotic plaque, we investigated the effect of atorvastatin (10 mg/kg/day) on plaque morphology. Atorvastatin did not lower plasma total cholesterol levels or affect plaque progression at this dosage; however, vulnerable plaque numbers were significantly reduced in the atorvastatin-treated group compared to control. Detailed examinations revealed that atorvastatin significantly decreased macrophage infiltration and subendothelial lipid deposition, reduced intimal collagen content, and elevated collagenase activity and expression of matrix metalloproteinases (MMPs). Because vascular inflammation is largely driven by changes in monocyte/macrophage numbers in the vessel wall, we speculated that the anti-inflammatory effect of atorvastatin may partially result from decreased monocyte recruitment to the endothelium. Further experiments showed that atorvastatin downregulated expression of the chemokines monocyte chemoattractant protein (MCP)-1, chemokine (C-X3-C motif) ligand 1 (CX3CL1) and their receptors CCR2 and, CX3CR1, which are mainly responsible for monocyte recruitment. In addition, levels of the plasma inflammatory markers C-reactive protein (CRP) and tumor necrosis factor (TNF)-α were also significantly decrease in atorvastatin-treated mice. Collectively, our results demonstrate that atorvastatin can improve plaque stability in mice independent of plasma cholesterol levels. Given the profound inhibition of macrophage infiltration into atherosclerotic plaques, we propose that statins may partly exert protective effects by modulating levels of chemokines and their receptors. These findings elucidate yet another atheroprotective mechanism of statins. |
format | Online Article Text |
id | pubmed-4016207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40162072014-05-14 Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors Nie, Peng Li, Dandan Hu, Liuhua Jin, Shuxuan Yu, Ying Cai, Zhaohua Shao, Qin Shen, Jieyan Yi, Jing Xiao, Hua Shen, Linghong He, Ben PLoS One Research Article It is well documented that statins protect atherosclerotic patients from inflammatory changes and plaque instability in coronary arteries. However, the underlying mechanisms are not fully understood. Using a previously established mouse model for vulnerable atherosclerotic plaque, we investigated the effect of atorvastatin (10 mg/kg/day) on plaque morphology. Atorvastatin did not lower plasma total cholesterol levels or affect plaque progression at this dosage; however, vulnerable plaque numbers were significantly reduced in the atorvastatin-treated group compared to control. Detailed examinations revealed that atorvastatin significantly decreased macrophage infiltration and subendothelial lipid deposition, reduced intimal collagen content, and elevated collagenase activity and expression of matrix metalloproteinases (MMPs). Because vascular inflammation is largely driven by changes in monocyte/macrophage numbers in the vessel wall, we speculated that the anti-inflammatory effect of atorvastatin may partially result from decreased monocyte recruitment to the endothelium. Further experiments showed that atorvastatin downregulated expression of the chemokines monocyte chemoattractant protein (MCP)-1, chemokine (C-X3-C motif) ligand 1 (CX3CL1) and their receptors CCR2 and, CX3CR1, which are mainly responsible for monocyte recruitment. In addition, levels of the plasma inflammatory markers C-reactive protein (CRP) and tumor necrosis factor (TNF)-α were also significantly decrease in atorvastatin-treated mice. Collectively, our results demonstrate that atorvastatin can improve plaque stability in mice independent of plasma cholesterol levels. Given the profound inhibition of macrophage infiltration into atherosclerotic plaques, we propose that statins may partly exert protective effects by modulating levels of chemokines and their receptors. These findings elucidate yet another atheroprotective mechanism of statins. Public Library of Science 2014-05-09 /pmc/articles/PMC4016207/ /pubmed/24816562 http://dx.doi.org/10.1371/journal.pone.0097009 Text en © 2014 Nie et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Nie, Peng Li, Dandan Hu, Liuhua Jin, Shuxuan Yu, Ying Cai, Zhaohua Shao, Qin Shen, Jieyan Yi, Jing Xiao, Hua Shen, Linghong He, Ben Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors |
title | Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors |
title_full | Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors |
title_fullStr | Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors |
title_full_unstemmed | Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors |
title_short | Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors |
title_sort | atorvastatin improves plaque stability in apoe-knockout mice by regulating chemokines and chemokine receptors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016207/ https://www.ncbi.nlm.nih.gov/pubmed/24816562 http://dx.doi.org/10.1371/journal.pone.0097009 |
work_keys_str_mv | AT niepeng atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT lidandan atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT huliuhua atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT jinshuxuan atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT yuying atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT caizhaohua atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT shaoqin atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT shenjieyan atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT yijing atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT xiaohua atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT shenlinghong atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors AT heben atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors |